CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
NDSN delivered strong Q2 FY 26 (Oct.) results, with sales of $741M (+8% Y/Y) and adjusted EPS of $2.86 (+18% Y/Y), beating consensus of $2.85. Organic sales growth of 7% was broad-based across segments, with favorable foreign exchange rates contributing an additional 3%. Order backlog growth of 18% was encouraging, reflecting demand recovery that we see providing stronger visibility and positioning NDSN well for growth. Management raised full-year guidance for both sales and adjusted EPS as demand conditions brighten. Segment performance was mixed, with Industrial Precision Solutions achieving 10% sales growth but experiencing 100-bps EBITDA margin compression to 35%. Advanced Tech Solutions was the standout performer, posting 8% organic growth while expanding EBITDA margins 200 bps to 27%, driven by strong electronics demand. Free cash flow conversion was robust at 113% of adjusted net income, enabling the strategic CapstanAG acquisition to expand precision agriculture capabilities.